Drugs Made In America Acquisition (DMAA) EBITDA (2025)
Drugs Made In America Acquisition's (DMAA) quarterly EBITDA came in at -$2.1 million in Q4 2025, down 692.36% on a QoQ basis from -$263703.0 in Q3 2025.
Drugs Made In America Acquisition (DMAA) EBITDA (2025) Analysis & Trends
Drugs Made In America Acquisition (DMAA) has 1 years of EBITDA data on file, last reported at -$2.1 million in Q4 2025.
- Quarterly EBITDA changed N/A year-over-year to -$2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.8 million (changed N/A YoY) and the FY2025 annual result came in at -$2.8 million, down 906.28% from the prior year.
- EBITDA slipped to -$2.1 million in Q4 2025, from -$263703.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$131919.0 in Q2 2025 to a low of -$2.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | -194,528.00 |
| 2 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | -112,227.00 |
| 3 | Cantor Equity Partners IV | 467.55 Mn | 467.55 Mn | - | -174,182.00 |
| 4 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | -1.47 Mn |
| 5 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | -115,742.00 |
| 6 | Gores Holdings X | 381.05 Mn | 380.85 Mn | - | -1.35 Mn |
| 7 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | - |
| 8 | Blue Water Acquisition Corp. III | 342.12 Mn | 342.08 Mn | - | -197,949.00 |
| 9 | Berto Acquisition | 313.96 Mn | 313.81 Mn | - | -1.62 Mn |
| 10 | Drugs Made In America Acquisition | 215.52 Mn | 215.52 Mn | - | -136,934.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.09 Mn |
| Sep 30, 2025 | -263,703.00 |
| Jun 30, 2025 | -131,919.00 |
| Mar 31, 2025 | -330,925.00 |